Literature DB >> 17130989

[Brain and spinal cord magnetic resonance imaging in spastic paraparesis associated to human T-lymphotropic virus].

Jorge Cervilla1, Luis Cartier, Luis García.   

Abstract

BACKGROUND: The spastic paraparesis associated to HTLV-1 causes degenerative pyramidal tract lesions of the spinal cord and affects cortical-nuclear connections in the brain. AIM: To report the findings of magnetic resonance imaging in patients with spastic paraparesis.
MATERIAL AND METHODS: A magnetic resonance imaging of the brain and spinal cord was performed in 30 patients (24 females), mean age and evolution of 56 and 12 years respectively, with a clinical and virological diagnosis of tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM).
RESULTS: No patient had abnormal signals in the spinal cord parenchyma. However, an atrophy of the dorsal segment was observed in 87% of patients. Patients with the highest degree of atrophy showed a higher degree of functional impairment. Eleven patients had spinal cord conus atrophy, associated to neurogenic bladder or impotency. In 80% of patients, hyperintense subcortical white matter images in DP, T2 and Flair, mostly bi frontal, were detected. In half of them, small rounded and isolated images were observed. In the other half, eight or more images, generally larger and occasionally confluent, were found. Ten of 12 patients with confluent brain lesions showed different degrees of cognitive impairment. No patient had lesions in the corpus callosus, periventricular white matter, pons, medulla oblongata or cerebellum.
CONCLUSIONS: Most patients with tropical spastic paraparesis have alterations in brain or spinal cord magnetic resonance imaging. The magnetic resonance lesions are concordant with functional impairment. The characteristics of the imaging in TSP/HAM patients can be helpful in the differential diagnosis of patients with paraparesis.

Entities:  

Mesh:

Year:  2006        PMID: 17130989     DOI: 10.4067/s0034-98872006000800010

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

1.  Case Report: Cognitive Impairment without Clinical Spinal Disease May Be the First Sign of HTLV-1 Neurological Alteration.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Denise Utsch-Gonçalves
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

2.  Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Carlos Vilchez; Massiel Gonzalez-Reinoso; Caroline Cubbison; Eddy Perez-Then; Pedro Roa; Adriano Martínez; Bernd Foerster; Jairo Oviedo; Peter Stoeter
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643

3.  Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.

Authors:  Massanobu Takatani; Myuki Esashika Crispim; Nelson Fraiji; Mariane Martins Araujo Stefani; Dagmar Kiesslich
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

4.  Electrophysiological analysis shows dizziness as the first symptom in human T cell lymphotropic virus type-associated myelopathy/tropical spastic paraparesis.

Authors:  Ludimila Labanca; Ana Lúcia Borges Starling; Silvio Roberto de Sousa-Pereira; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti; Lucas Novaes Carvalho; Daniele Rosa Fernandes; Denise Utsch Gonçalves
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-16       Impact factor: 2.205

5.  Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.

Authors:  Ludimila Labanca; Júlia Fonseca de Morais Caporali; Sirley Alves da Silva Carvalho; José Roberto Lambertucci; Anna Bárbara de Freitas Carneiro Proietti; Luiz Cláudio Ferreira Romanelli; Paul Avan; Fabrice Giraudet; Bárbara Oliveira Souza; Kyonis Rodrigues Florentino; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.